Cooper Companies (COO) Gains from Sales and Divestitures (2011)

Cooper Companies (COO) recorded quarterly Gains from Sales and Divestitures of $80850.0 in Q4 2011.

Cooper Companies (COO) Gains from Sales and Divestitures (2011) Analysis & Trends

Cooper Companies has disclosed Gains from Sales and Divestitures across 1 years of filings, most recently posting $80850.0 for Q4 2011.

For the quarter ending Q4 2011, Gains from Sales and Divestitures changed N/A year-over-year to $80850.0; the trailing twelve-month figure through Oct 2011 stood at $80850.0 (changed N/A YoY), and the FY2011 full-year result was $80850.0, changed N/A from the prior year.
Gains from Sales and Divestitures was $80850.0 for Q4 2011 at Cooper Companies.
Over five years, Gains from Sales and Divestitures peaked at $80850.0 in Q4 2011 and troughed at $80850.0 in Q4 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	148.09 Bn	143.69 Bn	1.83 Bn
2	Becton Dickinson	41.00 Bn	39.99 Bn	2.15 Bn
3	Medline	30.38 Bn	36.22 Bn	1.84 Bn
4	Resmed	28.22 Bn	26.56 Bn	890.98 Mn
5	West Pharmaceutical Services	23.72 Bn	23.19 Bn	296.40 Mn
6	Solventum	13.33 Bn	13.33 Bn	1.10 Bn
7	Cooper Companies	13.12 Bn	12.99 Bn	735.40 Mn
8	Align Technology	12.86 Bn	11.80 Bn	736.59 Mn
9	Baxter International	10.51 Bn	8.47 Bn	891.00 Mn
10	Aptargroup	7.72 Bn	7.52 Bn	351.91 Mn

Download Data

Date	Value
Oct 31, 2011	80,850.00
Oct 31, 2011	80,850.00